Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA-drug interaction measurements using surface plasmon resonance

G Bischoff1, R Bischoff, E Birch-Hirschfeld

  • 1Martin Luther University, Halle-Wittenberg, Institute of Biochemistry, Halle (Saale), Germany. bischoff@fu-berlin.de

Journal of Biomolecular Structure & Dynamics
|December 2, 1998
PubMed
Summary

This study investigated drug-DNA interactions using Surface Plasmon Resonance and Scanning Force Microscopy. Tilorone showed the strongest binding affinity to synthetic DNA, with 41 molecules interacting with a 36-base pair duplex.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Valid food intake measures of adult patients for use within the GLIM framework: A scoping review.

Clinical nutrition ESPEN·2026
Same author

Crash localization and traffic impact assessment via spatio-temporal analysis of connected vehicle data.

Accident; analysis and prevention·2025
Same author

Severe COVID-19 and its cardiopulmonary effects 6 and 18 months after hospital discharge.

Frontiers in cardiovascular medicine·2024
Same author

Network-driven discovery yields new insight into Shox2-dependent cardiac rhythm control.

Biochimica et biophysica acta. Gene regulatory mechanisms·2021
Same author

Treating patients with driving phobia by virtual reality exposure therapy - a pilot study.

PloS one·2020
Same author

Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.

Clinical hemorheology and microcirculation·2019

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biophysics

Background:

  • Understanding drug-DNA interactions is crucial for developing novel therapeutics.
  • Various small molecules are known to interact with DNA, influencing its structure and function.
  • Characterizing these interactions provides insights into molecular mechanisms and drug design.

Purpose of the Study:

  • To investigate the binding interactions of four distinct drugs with synthetic DNA using multiple biophysical techniques.
  • To quantify the binding affinity and stoichiometry of drug-DNA complexes.
  • To elucidate the structural and dynamic aspects of these interactions at the molecular level.

Main Methods:

  • Surface Plasmon Resonance (SPR) was employed to study drug-DNA interactions in real-time.

Related Experiment Videos

  • DNA was immobilized on a streptavidin-coated sensor chip for drug binding assays.
  • Scanning Force Microscopy (SFM) and polarizing microscopy were used to visualize DNA-drug complexes.
  • UV-absorption thermal denaturation was performed to assess DNA stability in the presence of drugs.
  • Computational simulations were utilized to complement experimental findings and understand interaction geometries.

    • Main Results:

    • Tilorone exhibited the highest binding affinity to the synthetic DNA duplex, with up to 41 molecules binding per 36-base pair DNA.
    • FA-2, Hoechst 33258, and hematoporphyrin IX derivative (HPD) also showed interactions with DNA, though with varying affinities.
    • SPR provided quantitative data on binding kinetics and mass changes.
    • SFM and polarizing microscopy offered insights into the microscopic behavior of DNA-drug complexes in condensed phases.
    • Thermal denaturation studies indicated alterations in DNA stability upon drug binding.

    Conclusions:

    • The study successfully characterized the interactions of Tilorone, FA-2, Hoechst 33258, and HPD with synthetic DNA.
    • Tilorone demonstrates a significant binding capacity to DNA, suggesting potential as a DNA-interacting agent.
    • The combination of SPR, SFM, thermal denaturation, and computational simulations provides a comprehensive understanding of drug-DNA interactions.
    • These findings contribute to the knowledge of molecular recognition between small molecules and nucleic acids.